Aurora Sánchez

ORCID: 0000-0003-1167-1451
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prenatal Screening and Diagnostics
  • Genomic variations and chromosomal abnormalities
  • Genetics and Neurodevelopmental Disorders
  • Genetic Neurodegenerative Diseases
  • Genetic Syndromes and Imprinting
  • Autism Spectrum Disorder Research
  • Mitochondrial Function and Pathology
  • Congenital Anomalies and Fetal Surgery
  • Chromosomal and Genetic Variations
  • Parvovirus B19 Infection Studies
  • Fetal and Pediatric Neurological Disorders
  • Muscle Physiology and Disorders
  • Genomics and Rare Diseases
  • Congenital heart defects research
  • Neurological disorders and treatments
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Family and Disability Support Research
  • Ubiquitin and proteasome pathways
  • Gestational Trophoblastic Disease Studies
  • Assisted Reproductive Technology and Twin Pregnancy
  • Comparative Literary Analysis and Criticism
  • Congenital Heart Disease Studies
  • Epigenetics and DNA Methylation
  • Neurogenetic and Muscular Disorders Research
  • Connective tissue disorders research

Hospital Clínic de Barcelona
2013-2025

Instituto de Investigación de Enfermedades Raras
2009-2025

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2010-2025

Instituto de Salud Carlos III
2010-2025

Centro de Investigación Biomédica en Red
2007-2025

Universitat de Barcelona
2004-2025

Instituto Cajal
2024

Centre for Biomedical Network Research on Rare Diseases
2009-2023

Institució Catalana de Recerca i Estudis Avançats
2022

Institut d'Investigació Biomédica de Bellvitge
2022

Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by expanded CAG repeats in the huntingtin ( HTT ) gene. Although several palliative treatments are available, there currently no cure and patients generally die 10–15 y after diagnosis. Several promising approaches for HD therapy development, including RNAi antisense analogs. We developed complementary strategy to test repression of mutant with zinc finger proteins (ZFPs) an model. tested “molecular tape...

10.1073/pnas.1206506109 article EN Proceedings of the National Academy of Sciences 2012-09-27

In order to contribute the knowledge of type and frequency chromosome abnormalities in early pregnancy losses, we analyzed cytogenetic results from a large series first trimester miscarriages, using diagnostic approach with high success rate no maternal contamination. A total 1,119 consecutive chorionic villi samples were obtained before evacuation, karyotypes prepared after short-term culture (STC). 603 samples, long-term (LTC) was also performed. The overall individual frequencies...

10.1159/000477707 article EN Cytogenetic and Genome Research 2017-01-01

Abstract Background Neurodevelopmental disorders (NDDs) are a group of heterogeneous conditions, which include mainly intellectual disability, developmental delay (DD) and autism spectrum disorder (ASD), among others. These diseases highly both genetic environmental factors play an important role in many them. The introduction next generation sequencing (NGS) has lead to the detection variants several diseases. main aim this report is discuss impact advantages implementation NGS diagnosis...

10.1186/s13023-022-02213-z article EN cc-by Orphanet Journal of Rare Diseases 2022-02-19

In this work, we investigated the effects of Casiopeina Il-gly (Cas ILgly)—a new copper compound exhibiting antineoplastic activity—on glioma C6 cells under both in vitro and vivo conditions, as an approach to identify potential therapeutic agents against malignant glioma. The exposure Cas Ilgly significantly inhibited cell proliferation, increased reactive oxygen species (ROS) formation, induced apoptosis a dose-dependent manner. cultured cells, caused mitochondrio-nuclear translocation...

10.1593/neo.04607 article EN cc-by-nc-nd Neoplasia 2005-06-01

Is there any effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage?There was no significant difference the chromosome abnormality between sporadic miscarriage but increased significantly with age.About 50-70% non-recurrent miscarriages occur because a anomaly, agreement about either or number previous has been reached.A retrospective cohort 353 successfully karyotyped same center 2002 2011, grouped according to age.Among women, 153 were below 35 years (73...

10.1093/humrep/des251 article EN Human Reproduction 2012-08-09

Abstract Conventional tissue culturing and karyotyping of spontaneous abortions has limitations such as culture failure, external contamination selective growth maternal cells. Molecular cytogenetic techniques FISH, QF‐PCR, CGH allow diagnosis on uncultured cells but are also limited to the spectrum abnormalities detected. We describe findings in a series 116 first trimester arrested pregnancies, obtained through chorionic villi sampling (CVS) semi‐direct analysis that avoids some...

10.1002/ajmg.a.32058 article EN American Journal of Medical Genetics Part A 2007-12-12

To assess the frequency of karyotype abnormalities and chromosome 22q11.2 deletion syndrome among fetuses with abnormal cardiac ultrasound findings, to evaluate clinical value chromosomal microarray-based analysis (CMA) in study such pregnancies.First, we carried out retrospective cases diagnosed between January 2009 December 2011 our center findings (n = 276). Second, CMA was performed 51 normal negative or no study, only fetus a heart defect an apparently balanced de novo rearrangement.Out...

10.1002/uog.12372 article EN Ultrasound in Obstetrics and Gynecology 2012-12-11

The term neuromuscular disorder (NMD) includes many genetic and acquired diseases differential diagnosis can be challenging. Next-generation sequencing (NGS) is especially useful in this setting given the large number of possible candidate genes, clinical, pathological, heterogeneity, absence an established genotype-phenotype correlation, exceptionally size some causative genes such as TTN, NEB RYR1. We evaluated diagnostic value a custom targeted next-generation gene panel to study...

10.3390/genes11050539 article EN Genes 2020-05-11

<b><i>Background:</i></b> Myotonic dystrophy type 1 (DM1) is associated with the expansion of an unstable CTG repeat. Larger alleles are a more severe form disease and almost always increase in length from one generation to next, accounting for clinical anticipation characteristic DM1. As such, expanded rapidly lost population. However, incidence appears remain constant. It was authors' our aim determine frequency germline stability DM1 premutation that give rise new families....

10.1212/wnl.56.3.328 article EN Neurology 2001-02-13

Abstract Objective To assess the effectiveness of Combined Test in prenatal detection trisomy 21 general pregnant population using a new timing for screening approach. Methods First‐trimester maternal serum biochemical markers (pregnancy‐associated plasma protein‐A and free‐β hCG) were determined at 7 to 12 weeks. Fetal nuchal translucency gestational age assessed 10‐ 14‐week ultrasound scan. A combined risk was estimated delivered women same day. When 1:250 or above, chorionic villus...

10.1002/pd.949 article EN Prenatal Diagnosis 2004-07-01

Abstract Background Aproximately 5–10% of cases mental retardation in males are due to copy number variations (CNV) on the X chromosome. Novel technologies, such as array comparative genomic hybridization (aCGH), may help uncover cryptic rearrangements X-linked (XLMR) patients. We have constructed an X-chromosome tiling path using bacterial artificial chromosomes (BACs) and validated it samples with cytogenetically defined changes. studied 54 patients idiopathic 20 controls subjects. Results...

10.1186/1471-2164-8-443 article EN cc-by BMC Genomics 2007-11-29

Nuclear transfer experiments undertaken in the mid-80's revealed that both maternal and paternal genomes are necessary for normal development. This is due to genomic imprinting, an epigenetic mechanism results parent-of-origin monoallelic expression of genes regulated by germline-derived allelic methylation. To date, ∼100 imprinted transcripts have been identified mouse, with approximately two-thirds showing conservation humans. It currently unknown how many present humans, what extent these...

10.1093/hmg/ddr224 article EN Human Molecular Genetics 2011-05-18

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder affecting 1:3,500 individuals. Disease expression highly variable and complications are diverse. However, currently there no specific treatment for the disease. NF1 caused by mutations in gene, approximately 2.1% of constitutional identified our population deep intronic producing insertion a cryptic exon into mature mRNA. We used antisense morpholino oligomers (AMOs) to restore normal splicing primary fibroblast lymphocyte cell...

10.1002/humu.20933 article EN Human Mutation 2009-02-24

To assess the perinatal and pediatric outcomes up to 2 years of age in singleton karyotypically normal fetuses with increased nuchal translucency (NT) above 99(th) percentile.Singleton NT percentile karyotype scanned our center from 2002 2006 were included. Work-up included first- second-trimester anomaly scan, fetal echocardiography, selected cases infection screening genetic testing. Among survivors, a follow-up was undertaken.During this 4-year period, 171 study. There seven spontaneous...

10.1002/uog.10059 article EN Ultrasound in Obstetrics and Gynecology 2011-08-11
Gemma Bullich Leslie Matalonga Montserrat Pujadas Anastasios Papakonstantinou Davide Piscia and 95 more Raúl Tonda Rafael Artuch P. Gallano Glòria Garrabou Juan R. González Daniel Grinberg Míriam Guitart Steven Laurie Conxi Lázaro Cristina Luengo Ramón Martí Montserrat Milà David Ovelleiro Genı́s Parra Aurora Pujol Eduardo F. Tizzano Alfons Macaya Francesc Palau Antònia Ribes Luis A. Pérez‐Jurado Sergi Beltrán Agatha Schlüter Agustí Rodríguez‐Palmero Alejandro Cáceres A. Nascimento Àngels García‐Cazorla Anna M. Cueto‐González Anna Marcé‐Grau A. Lô Antonio Federico Martínez‐Monseny Aurora Sánchez Belén de la Fuente García Belén Pérez‐Dueñas Bernat Gel Berta Fusté Carles Hernández-Ferrer Carlos Casasnovas C. Ortez César Arjona Cristina Hernando‐Davalillo Daniel Natera‐de Benito Daniel Picó Amador David Gómez‐Andrés Dèlia Yubero Dolors Pelegrí-Sisó Edgard Verdura Elena García‐Arumí Elisabeth Castellanos Elisabeth Gabau Ester Tobías Fermina López‐Grondona Francesc Cardellach Francesc Josep García‐García Francina Munell Frederic Tort Gemma Aznar Gemma Olivé-Cirera Gemma Tell‐Martí Gerard Muñoz-Pujol Ida Paramonov Ignacio Blanco Irene Madrigal Irene Valenzuela Marta Gut Ivon Cuscó Jean-Rémi Trotta Jordi Cruz Jordi Díaz‐Manera José C. Milisenda Josep Ma Grau Judit García‐Villoria Judith Armstrong Judith Cantó Júlia Sala‐Coromina Laia Rodríguez‐Revenga Laura Alías Laura Gort Lídia González-Quereda Mar Costa Marcos Fernández-Callejo Marcos López‐Sánchez María Isabel Álvarez‐Mora Marta Gut Mercedes Serrano Miquel Raspall‐Chaure Mireia del Toro Mónica Bayés Neus Baena Díez Nino Spataro Núria Capdevila Olatz Ugarteburu Patricia Muñoz‐Cabello P. Romero Duque Raquel Rabionet Ricard Rojas‐García

Many patients experiencing a rare disease remain undiagnosed even after genomic testing. Reanalysis of existing data has shown to increase diagnostic yield, although there are few systematic and comprehensive reanalysis efforts that enable collaborative interpretation future reinterpretation. The Undiagnosed Rare Disease Program Catalonia project collated previously inconclusive good quality (panels, exomes, genomes) standardized phenotypic profiles from 323 families (543 individuals) with...

10.1016/j.jmoldx.2022.02.003 article EN cc-by-nc-nd Journal of Molecular Diagnostics 2022-05-01
Coming Soon ...